Medpace (MEDP) Competitors $501.76 +3.94 (+0.79%) As of 12:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEDP vs. ICLR, EHC, ELV, HIMS, IQV, TCOM, WCN, RDDT, AER, and CPAYShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include ICON (ICLR), Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), Trip.com Group (TCOM), Waste Connections (WCN), Reddit (RDDT), Aercap (AER), and Corpay (CPAY). Medpace vs. Its Competitors ICON Encompass Health Elevance Health Hims & Hers Health IQVIA Trip.com Group Waste Connections Reddit Aercap Corpay Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation. Do analysts recommend MEDP or ICLR? Medpace currently has a consensus target price of $422.27, indicating a potential downside of 15.84%. Icon has a consensus target price of $216.67, indicating a potential upside of 22.14%. Given Icon's stronger consensus rating and higher possible upside, analysts plainly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 3 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.94Icon 0 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.68 Which has more volatility and risk, MEDP or ICLR? Medpace has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Which has stronger earnings & valuation, MEDP or ICLR? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B6.68$404.39M$13.4537.31Icon$8.28B1.73$791.47M$9.7218.25 Do institutionals and insiders believe in MEDP or ICLR? 78.0% of Medpace shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 20.3% of Medpace shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer MEDP or ICLR? In the previous week, Medpace had 10 more articles in the media than Icon. MarketBeat recorded 18 mentions for Medpace and 8 mentions for Icon. Medpace's average media sentiment score of 1.20 beat Icon's score of 0.54 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 13 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Icon 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is MEDP or ICLR more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Icon 9.82%10.95%6.23% SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.09B$7.61B$5.75B$10.36BDividend YieldN/A2.84%5.86%4.62%P/E Ratio37.3177.6076.6126.83Price / Sales6.6834.98452.6189.74Price / Cash35.1824.0537.2260.63Price / Book18.897.1013.926.37Net Income$404.39M$241.92M$3.29B$271.28M7 Day Performance0.84%0.24%0.26%1.87%1 Month Performance8.39%1.92%4.92%7.43%1 Year Performance38.88%3.07%85.89%30.62% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.3137 of 5 stars$501.77+0.8%$422.27-15.8%+40.4%$14.09B$2.11B37.315,900Positive NewsICLRICON4.0153 of 5 stars$177.81+1.7%$219.64+23.5%-40.1%$14.12B$8.28B13.5941,900EHCEncompass Health4.7996 of 5 stars$125.93+0.3%$134.00+6.4%+36.1%$12.65B$5.37B25.2740,000Analyst ForecastShort Interest ↑ELVElevance Health4.9211 of 5 stars$308.03-1.8%$411.06+33.4%-43.3%$70.62B$177.01B9.50104,200Positive NewsHIMSHims & Hers Health2.8062 of 5 stars$49.77+2.8%$38.92-21.8%+212.5%$10.94B$1.48B89.651,637Trending NewsInsider TradeIQVIQVIA4.9509 of 5 stars$187.72+0.0%$229.86+22.4%-22.2%$31.91B$15.41B18.0388,000Positive NewsTCOMTrip.com Group3.8953 of 5 stars$73.02+0.3%$76.98+5.4%+64.6%$47.55B$7.30B22.0641,073Positive NewsWCNWaste Connections4.9397 of 5 stars$178.44-0.5%$215.00+20.5%-4.4%$46.10B$8.92B36.3723,854Analyst ForecastRDDTReddit3.3742 of 5 stars$230.54-3.9%$175.38-23.9%+330.8%$44.92B$1.30B218.182,233Trending NewsAnalyst ForecastInsider TradeGap UpAERAercap2.3603 of 5 stars$123.00-0.4%$122.57-0.3%+27.4%$23.07B$8.00B10.10740Short Interest ↑CPAYCorpay4.2983 of 5 stars$311.60-1.6%$399.43+28.2%+1.2%$22.36B$3.97B16.8311,200Positive News Related Companies and Tools Related Companies ICON Alternatives Encompass Health Alternatives Elevance Health Alternatives Hims & Hers Health Alternatives IQVIA Alternatives Trip.com Group Alternatives Waste Connections Alternatives Reddit Alternatives Aercap Alternatives Corpay Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEDP) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDP Stock Alerts